Investigadors
-
Begoña Pina Marín
Oftalmologia
-
Carlos Luis Moser Würth
Oftalmologia
-
Carlos Martínez Belló
Oftalmologia
-
Diana Paola Mora Ramirez
Oftalmologia
-
Joan Josep Escobar Barranco
Oftalmologia
-
Josep Badal Lafulla
Oftalmologia
Phd -
Luis Amselem Gómez
Oftalmologia
-
Magela Garat Chifflet
Oftalmologia
-
Manel Fernández Bonet
Oftalmologia
-
Mónica Lecumberri López
Oftalmologia
-
Rafel Alcubierre Bailac
Oftalmologia
-
Sabrina Bojados
Oftalmologia
-
Stephany Carrillo
Oftalmologia
Contacteu amb el grup
Formulari
Projectes
-
- Any 2013
- Comprehensive Care Center Dos de Maig Hospital
Retrospective observational study to determine the clinical evolution of patients with age-related macular degeneration, treated with long-term ranibizumab in routine clinical practice,
-
PROMOTOR:
Novartis Farmaceútica, SA
-
TIPUS E:
EPA
- Any 2013
- Comprehensive Care Center Dos de Maig Hospital
Unicentric retrospective observational study to describe the management of patients with visual impairment secondary to diabetic macular edema treated with ranibizumab alone or in combination with other treatments based on individualized follow-up,
-
PROMOTOR:
Integral Health Consortium
-
TIPUS E:
PINE TREE
- Any 2013
- Sant Joan Despí Moisès Broggi Hospital
Descriptive study on the management of patients with Diabetic Macular Edema and Macular Edema Secondary to Venous Occlusion of the Retina by the retinologist specialist and Adherence to the official recommendations of the Spanish Retina and Vitreous Society (SERV). Study OBSERVER.
-
PROMOTOR:
Novartis Farmaceútica SA,
-
TIPUS E:
EPA
- Any 2013
- Comprehensive Care Center Dos de Maig Hospital
Study to observe the effectiveness and safety of Lucentis through the individualized treatment of the patient and the associated results,
-
PROMOTOR:
Novartis Pharma AG
-
TIPUS E:
EPA
- Any 2013
- Sant Joan Despí Moisès Broggi Hospital
Phase IV clinical trial to evaluate the genetic variants of the VEGF pathway as biomarkers of the efficacy of treatment with aflibercept in patients with neovascular age-related macular degeneration (AMD),
-
PROMOTOR:
Research Foundation of the Institute of Ocular Microsurgery
-
TIPUS E:
RD2004
Línies d’actuació- Treatment of retinal diseases with intravitreal medication
- Anti VEGF in diabetic macular edema
- Anti VEGF in central serous chorioretinopathy
- Treatment of Diabetic Retinopathy
- UTI (Unitat de teràpia intravitria )
- New techniques in cataract surgery
- Surgical alternatives to full thickness corneal transplantation
- Microkeratum assisted keratoplasty Anterior and posterior lamellar techniques
Documents
Informació d’interès
Enllaços
